Skip to content

Clinical trials

Lymphoma, Large-Cell, Anaplastic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20052
20061
20081
20092
20122
20132
20151
20161
20182
20201
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Recruiting2
Unknown status2
No longer available1
Withdrawn1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Seagen Inc.4
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
BeiGene1
Boston Medical Center1
European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma1
Gustave Roussy, Cancer Campus, Grand Paris1
Hoffmann-La Roche1
Institut Paoli-Calmettes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic25
Lymphoma12
Lymphoma, Non-Hodgkin12
Hodgkin Disease11
Lymphoma, Large B-Cell, Diffuse9
Immunoblastic Lymphadenopathy8
Lymphoma, T-Cell, Cutaneous8
Burkitt Lymphoma7
Lymphoma, Follicular7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.